Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 4Lymphoid 2Gynecologic 2Genitourinary 2

Conditions

Ovarian Neoplasms 2Lymphoma 2Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Neoplasm Metastasis 1Leukemia 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 10pembrolizumab 9Therapeutics 8Flow Cytometry 6Radiotherapy 5Gemcitabine 5Blood Specimen Collection 5Surveys and Questionnaires 4Sirolimus 4Psychiatric Rehabilitation 4Peripheral Blood Stem Cell Transplantation 4Paclitaxel 4Nivolumab 4Methods 4Ipilimumab 4Filgrastim 4Exercise 4Drug Therapy 4Doxorubicin 4Capecitabine 4copanlisib 3aldesleukin 3Rituximab 3Polymerase Chain Reaction 3Immunologic Techniques 3Immunoglobulin G 3Immunoenzyme Techniques 3Fluorodeoxyglucose F18 3Early Intervention, Educational 3Disulfides 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × valspodar × Lymphoid × Clear all
NCT00001302 2008-03-04

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
80 enrolled
BreastGenitourinaryGynecologicLymphoid

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Neoplasm Metastasis, Ovarian Neoplasms

NCT00001383 2008-03-04

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
52 enrolled
BreastGenitourinaryGynecologicLymphoid

Breast Neoplasms, Carcinoma, Renal Cell, Lymphoma, Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡